Marinò M - Search Results

1

Total thyroid ablation in Graves' orbitopathy.

Menconi F, Leo M, Vitti P, Marcocci C, Marinò M. Menconi F, et al. Among authors: marino m. J Endocrinol Invest. 2015 Aug;38(8):809-15. doi: 10.1007/s40618-015-0255-1. Epub 2015 Mar 5. J Endocrinol Invest. 2015. PMID: 25740065 Review.

2

Serum soluble interleukin 2 (IL-2) receptor (sIL-2R) in differentiated thyroid carcinoma.

Mariotti S, Barbesino G, Caturegli P, Marinò M, Manetti L, Fugazzola L, Pacini F, Pinchera A. Mariotti S, et al. Among authors: marino m. J Endocrinol Invest. 1994 Dec;17(11):861-7. doi: 10.1007/BF03347792. J Endocrinol Invest. 1994. PMID: 7745234

3

Chronic recurrent stress due to panic disorder does not precipitate Graves' disease.

Chiovato L, Marinò M, Perugi G, Fiore E, Montanelli L, Lapi P, Cavaliere R, Ciampi M, Patronelli A, Placidi G, Placidi GF, Cassano GB, Pinchera A. Chiovato L, et al. Among authors: marino m. J Endocrinol Invest. 1998 Dec;21(11):758-64. doi: 10.1007/BF03348042. J Endocrinol Invest. 1998. PMID: 9972676

4

Increased frequency of euthyroid ophthalmopathy in patients with Graves' disease associated with myasthenia gravis.

Marinò M, Barbesino G, Pinchera A, Manetti L, Ricciardi R, Rossi B, Muratorio A, Braverman LE, Mariotti S, Chiovato L. Marinò M, et al. Thyroid. 2000 Sep;10(9):799-802. doi: 10.1089/thy.2000.10.799. Thyroid. 2000. PMID: 11041457

5

Targeting of thyroglobulin to transcytosis following megalin-mediated endocytosis: evidence for a preferential pH-independent pathway.

Marinò M, Lisi S, Pinchera A, Chiovato L, McCluskey RT. Marinò M, et al. J Endocrinol Invest. 2003 Mar;26(3):222-9. doi: 10.1007/BF03345161. J Endocrinol Invest. 2003. PMID: 12809172

6

Impaired thyroglobulin (Tg) secretion by FRTL-5 cells transfected with soluble receptor associated protein (RAP): evidence for a role of RAP in the Tg biosynthetic pathway.

Lisi S, Chiovato L, Pinchera A, Marcocci C, Menconi F, Morabito E, Altea MA, McCluskey RT, Marinò M. Lisi S, et al. Among authors: marino m. J Endocrinol Invest. 2003 Nov;26(11):1105-10. doi: 10.1007/BF03345258. J Endocrinol Invest. 2003. PMID: 15008249

7

Role of thyroglobulin in the pathogenesis of Graves' ophthalmopathy: the hypothesis of Kriss revisited.

Marinò M, Chiovato L, Lisi S, Altea MA, Marcocci C, Pinchera A. Marinò M, et al. J Endocrinol Invest. 2004 Mar;27(3):230-6. doi: 10.1007/BF03345271. J Endocrinol Invest. 2004. PMID: 15164998 Review.

8

Novel aspects of immunosuppressive and radiotherapy management of Graves' ophthalmopathy.

Marcocci C, Marinò M, Rocchi R, Menconi F, Morabito E, Pinchera A. Marcocci C, et al. Among authors: marino m. J Endocrinol Invest. 2004 Mar;27(3):272-80. doi: 10.1007/BF03345277. J Endocrinol Invest. 2004. PMID: 15165004 Review.

9

Failure to use measurement of megalin secretory components complexed with serum thyroglobulin as a tool to identify metastases after surgery in papillary thyroid cancer.

Lisi S, Menconi F, Altea MA, Agate L, Molinaro E, Castagna MG, Taddei D, Grasso L, Pinchera A, Elisei R, Marinò M. Lisi S, et al. Among authors: marino m. J Endocrinol Invest. 2004 Jul-Aug;27(7):636-42. doi: 10.1007/BF03347495. J Endocrinol Invest. 2004. PMID: 15505986 Clinical Trial.

10

Autoimmune hepatitis during intravenous glucocorticoid pulse therapy for Graves' ophthalmopathy treated successfully with glucocorticoids themselves.

Marinò M, Morabito E, Altea MA, Ambrogini E, Oliveri F, Brunetto MR, Pollina LE, Campani D, Vitti P, Bartalena L, Pincheral A, Marcocci C. Marinò M, et al. J Endocrinol Invest. 2005 Mar;28(3):280-4. doi: 10.1007/BF03345386. J Endocrinol Invest. 2005. PMID: 15952415

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,357 results

Search Page